Clinical Trials Directory

Trials / Completed

CompletedNCT06417515

The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia

Exploring Changes in Sleep Assessment of Patients With Sleep-related Diseases Treated by Chinese Medicine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Yu-Ching HSU · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The investigators recruited patients ages 20-65 from 2 groups in Tainan Hospital. One was from a weight loss class, also called WLC, one was from our regular clinic. These patients have no history of schizophrenia, narcolepsy, neurological disease, alcohol and drug addiction but had Pittsburgh Sleep Quality Index (PSQI) scores for psychometric properties ≥ 5 between January 1 to November 30 of 2019. The study group were the patients who received XYS for 28 days and the control group were those who didn't receive any Chinese medicine but attended the WLC. Age, gender, personal biodata, polysomnography findings, and these subjective sleep questionnaires were collected. The Wilcoxon test was used to compare the difference in pre and post evaluation in two groups. After comparing the objective and subjective assessment between the better and poorer performance in the XYS group, we would find more suitable criteria for XYS in traditional Chinese medicine.

Conditions

Interventions

TypeNameDescription
DRUGXiao-Yao-SanPatients who received Xiao-Yao-San 9 g/day (Kaiser Pharmaceutical Co. Ltd.) were selected for the Xiao-Yao-San group by traditional Chinese doctor with 8 years of experience.
OTHERWeight loss class(WLC) groupParticipants who attended the WLCs in our hospital and were willing to participate in our study were included in the WLC group (control group). Our WLCs consisted of 8 sessions of 2-hour dietary advice/exercise guidance and 1 session of weight-loss consultation in 3 months. The participants assessed their weights at the beginning, at 1.5 months, and after every class. They underwent pre-PSG tests in the beginning and post-PSG tests after 3 months of lectures.

Timeline

Start date
2019-01-01
Primary completion
2019-11-30
Completion
2019-11-30
First posted
2024-05-16
Last updated
2024-10-24

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06417515. Inclusion in this directory is not an endorsement.

The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia (NCT06417515) · Clinical Trials Directory